Nanofiber technology has emerged as a transformative platform in the realm of cancer therapeutics, bridging the disciplines of polymer chemistry, materials science, and biomedical engineering. This editorial highlight the multifaceted roles nanofibers play in cancer management, emphasizing how chemistry-driven design enables targeted, responsive, and sustained drug delivery systems. The editorial explores the application of nanofiber systems across diverse cancer types including brain, breast, lung, liver, colorectal, and gynaecological cancers showcasing their adaptability to organ-specific challenges and tumor microenvironments. Despite significant advancements, challenges related to scalability, regulatory approval, long-term safety, and cost-effectiveness remain.
Keywords: Nanofiber, Polymers, Drug delivery, Targeted delivery, Oncology.
×
How to Cite This Article
Vancouver
Kapoor DU, Prajapati BG. From chemistry to clinic: The transformative role of nanofibers in cancer management [Internet]. IP Int J Compr Adv Pharmacol. 2025 [cited 2025 Sep 13];10(2):75-76. Available from: https://doi.org/10.18231/j.ijcaap.2025.011
APA
Kapoor, D. U., Prajapati, B. G. (2025). From chemistry to clinic: The transformative role of nanofibers in cancer management. IP Int J Compr Adv Pharmacol, 10(2), 75-76. https://doi.org/10.18231/j.ijcaap.2025.011
MLA
Kapoor, Devesh U, Prajapati, Bhupendra G. "From chemistry to clinic: The transformative role of nanofibers in cancer management." IP Int J Compr Adv Pharmacol, vol. 10, no. 2, 2025, pp. 75-76. https://doi.org/10.18231/j.ijcaap.2025.011
Chicago
Kapoor, D. U., Prajapati, B. G.. "From chemistry to clinic: The transformative role of nanofibers in cancer management." IP Int J Compr Adv Pharmacol 10, no. 2 (2025): 75-76. https://doi.org/10.18231/j.ijcaap.2025.011